Moleküler Yolaklar
Normal hücreler, diğer hücresel streslerin yanı sıra
DNA hasarına yanıt olarak apoptozu başlatabilir.
Buna karşılık, kanser hücreleri genellikle benzer streslere karşı daha az hassastır ve apoptozdan kaçınma eğilimindedir.
PD-L1 yolağı inhibisyonunun temel alınması eş zamanlı olarak hedeflenebilen yolakları araştırarak kanser immünoterapisine ilişkin bilgileri arttırmaktadır
Referanslar
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646-674. PMID: 21376230
- Nguyen DX, Bos PD, Massagué J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9:274-284. PMID: 19308067
- Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer. 2009;9:239-252. PMID: 19279573
- Artandi SE, DePinho RA. Telomeres and telomerase in cancer. Carcinogenesis. 2010;31:9-18. PMID: 19887512
- Ringshausen I, Peschel C, Decker T. Cell cycle inhibition in malignant lymphoma: disease control by attacking the cellular proliferation machinery. Curr Drug Targets. 2006;7:1349-1359. PMID: 17073597
- Caldon CE, Sutherland RL, Musgrove EA. Cell cycle proteins in epithelial cell differentiation: implications for breast cancer. Cell Cycle. 2010;9:1918-1928. PMID: 20473028
- Sherr CJ. Principles of tumor suppression. Cell. 2004;116:235-246. PMID: 14744434
- Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer. 2009;125:1747-1754. PMID: 19444916
- Teng MW, Swann JB, Koebel CM, Schreiber RD, Smyth MJ. Immune-mediated dormancy: an equilibrium with cancer. J Leukoc Biol. 2008;84:988-993. PMID: 18515327
- Prendergast GC. Immune escape as a fundamental trait of cancer: focus on IDO. Oncogene. 2008;27:3889-3900. PMID: 18317452
- Dunn GP, Koebel CM, Schreiber RD. Interferons, immunity and cancer immunoediting. Nat Rev Immunol. 2006;6:836-848. PMID: 17063185
- Venkitaraman AR. Functions of BRCA1 and BRCA2 in the biological response to DNA damage. J Cell Sci. 2001;114(pt 20):3591-3598. PMID: 11707511
- Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 2005;23:1011-1027. PMID: 15585754
- Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003;3:401-410. PMID: 12778130
- Jones RG, Thompson CB. Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev. 2009;23:537-548. PMID: 19270154
- Chen K, Chen X. Positron emission tomography imaging of cancer biology: current status and future prospects. Semin Oncol. 2011;38:70-86. PMID: 21362517
- Marie SK, Shinjo SM. Metabolism and brain cancer. Clinics (Sao Paulo). 2011;66(suppl 1):33-43. PMID: 21779721
- Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther. 2005;4:139-163. PMID: 15725726
- Letai AG. Diagnosing and exploiting cancer’s addiction to blocks in apoptosis. Nat Rev Cancer. 2008;8:121-132. PMID: 18202696
- Hermann MT, Lowe SW. The p53-Bcl-2 connection. Cell Death Differ. 2006;13:1256-1259. PMID: 16710363
- Devarajan E, Sahin AA, Chen JS, et al. Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Oncogene. 2002;21:8843-8851. PMID: 12483536
- Quintavalle C, Donnarumma E, Iaboni M, et al. Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells. Oncogene. 2013;32:4001-4008. PMID: 22964638
- Bardeesy N, Sharpless NE. RAS unplugged: negative feedback and oncogene-induced senescence. Cancer Cell. 2006;10:451-453. PMID: 17157783
- Grivennikov SI, Karin M. Inflammation and oncogenesis: a vicious connection. Curr Opin Genet Dev. 2010;20:65-71. PMID: 20036794